A randomized trial of implantable cardioverter defibrillator use as primary prevention in subjects with ischemic cardiomyopathy.
A randomized trial of implantable cardioverter defibrillator use as primary prevention in subjects with ischemic cardiomyopathy. Curr Cardiol Rep. 2002 Sep; 4(5):361.